AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Anemia, RefractoryRefractory Period, ElectrophysiologicalTerminology as TopicAnemia, Refractory, with Excess of BlastsTreatment OutcomeSalvage TherapyRecurrenceDrug Administration ScheduleAntineoplastic Combined Chemotherapy ProtocolsRemission InductionAntineoplastic AgentsDrug Resistance, NeoplasmTime FactorsRetrospective StudiesFollow-Up StudiesAntibodies, Monoclonal, Murine-DerivedTreatment FailureDrug ResistanceAnticonvulsantsThalidomideInfusions, IntravenousEpilepsyAntibodies, MonoclonalCytarabineProspective StudiesRefractory Period, PsychologicalSeverity of Illness IndexDose-Response Relationship, DrugBoronic AcidsPyrazinesEtoposideConsensusNeoplasmsPrognosisUnited StatesMultiple MyelomaDrug EvaluationLymphoma, Non-HodgkinMaximum Tolerated DoseRisk FactorsNeoplasm Recurrence, LocalDisease-Free SurvivalTransplantation, AutologousHodgkin DiseaseAnemia, SideroblasticReproducibility of ResultsEpilepsies, PartialDrug Therapy, CombinationSurvival AnalysisChronic DiseasePain, IntractableArabinonucleosidesPrevalenceHeart Conduction SystemImmunosuppressive AgentsSensitivity and SpecificityCombined Modality TherapyVidarabinePiracetamSurvival RateCyclophosphamideMyelodysplastic SyndromesHematopoietic Stem Cell TransplantationCohort StudiesDisease ProgressionClinical Trials as TopicThrombocytopeniaAtrioventricular NodeCardiac Pacing, ArtificialAnti-Arrhythmia AgentsRetreatmentPredictive Value of TestsElectrocardiographyAcute DiseaseAtrial FibrillationAlgorithmsAscitesIncidenceMolecular Sequence DataHeart AtriaVagus Nerve StimulationLeukemia, Myeloid, AcuteStatus EpilepticusAdministration, OralMetabolic Syndrome XNitrogen Mustard CompoundsPurpura, Thrombocytopenic, IdiopathicWorld Health OrganizationMitoxantroneDexamethasoneIfosfamideLeukemia, Lymphocytic, Chronic, B-CellEndpoint DeterminationNeutropeniaPilot ProjectsImmunologic FactorsRisk AssessmentAntirheumatic AgentsLeukemiaAntibodies, Monoclonal, Humanized